ORCL
33
7
BRK.B
33
-14
RCL
68
4
HSY
43
2
CMI
71
2
SE
49
2
SNA
52
2
STI
18
11
REGN
59
2
HRB
46
4
VFC
70
2
WHR
50
-5
KO
44
-2
INTC
43
6
KR
37
-5
HPE
75
7
L
71
2
MU
75
4
BAX
38
-12
NI
65
-2
ORCL
33
7
BRK.B
33
-14
RCL
68
4
HSY
43
2
CMI
71
2
SE
49
2
SNA
52
2
STI
18
11
REGN
59
2
HRB
46
4
VFC
70
2
WHR
50
-5
KO
44
-2
INTC
43
6
KR
37
-5
HPE
75
7
L
71
2
MU
75
4
BAX
38
-12
NI
65
-2
Financhill
Back

Keros Therapeutics, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56

KROS
Keros Therapeutics, Inc.

Last Price:
$20.21
Seasonality Move:
4.91%

7 Day Trial

ALL ACCESS PASS

$ 7

Keros Therapeutics, Inc. Stock Forecast

  • Over the next 52 weeks, Keros Therapeutics, Inc. has on average historically fallen by 21.1% based on the past 5 years of stock performance.
  • Keros Therapeutics, Inc. has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
  • Is Keros Therapeutics, Inc. Stock Undervalued?
    The current Keros Therapeutics, Inc. [KROS] share price is $20.26. The Score for KROS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • KROS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Keros Therapeutics, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Keros Therapeutics, Inc. has on average historically fallen by 21.1% based on the past 5 years of stock performance.

Keros Therapeutics, Inc. Stock Rating

Buy
56
Keros Therapeutics, Inc. (KROS) is a Buy

Is Keros Therapeutics, Inc. overpriced?

  • Keros Therapeutics, Inc. has fallen lower in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%

Keros Therapeutics, Inc. Stock Price History

Is KROS stock going to rise?

  • The current trend is moderately bullish and KROS is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kerostx.com

52-Week Data

52-Week High:
22.55
52-Week Low:
9.12

Prediction Charts

Market Cap:
617.2M
Price in USD:
20.26
Volume:
2.1M
Beta:
1.15

Technical Analysis

SMA50:
17.33
SMA100:
16.26
SMA200:
14.75
52-Wk Change:
19.74%

Stock Predictions

  • Is Keros Therapeutics, Inc. stock public?
    Yes, Keros Therapeutics, Inc. is a publicly traded company.
  • What is the Keros Therapeutics, Inc. stock quote today?
    The Keros Therapeutics, Inc. stock price is 20.26 USD today.
  • How to buy Keros Therapeutics, Inc. stock online?
    You can buy Keros Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-2 17.18 16.83 17.18 16.75
Dec-3 16.93 18.10 18.44 16.93
Dec-4 18.10 20.27 20.35 17.95
Dec-5 20.26 21.69 21.93 20.26
Dec-8 21.72 21.32 22.55 21.27
Dec-9 21.15 21.53 22.00 20.78
Dec-10 21.69 21.84 22.20 21.33
Dec-11 21.77 21.69 22.11 21.42
Dec-12 21.82 21.51 21.91 21.41
Dec-15 21.09 21.23 21.29 20.73
Dec-16 21.16 21.53 21.73 20.85
Dec-17 21.60 20.83 21.75 20.66
Dec-18 20.74 20.13 21.05 19.84
Dec-19 20.19 20.26 20.27 19.76

Keros Therapeutics, Inc. Earnings

Keros Therapeutics, Inc. Earnings Report: Per Share Keros Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Keros Therapeutics, Inc. Forecast Revenue Growth

Keros Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Keros Therapeutics, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.45 per share, and a decrease next year of $5.27 per share.

* Keros Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.